Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
Ejhaem
|
July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease
Hirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
BMJ Supportive & Palliative Care
|
April 3, 2024
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study
Mamiko Takahashi, Shin Kondo, Kumiko Kagawa, et al.
Journal of Diabetes Investigation
|
January 25, 2019
Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Hiroyasu Mori, Akio Kuroda, Masashi Ishizu, et al.
Diabetes Technology & Therapeutics
|
October 30, 2012
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump
Akio Kuroda, Tetsuyuki Yasuda, Mitsuyoshi Takahara, et al.
Journal of Atherosclerosis and Thrombosis
|
May 16, 2017
The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice
Kiyoe Kurahashi, Seika Inoue, Sumiko Yoshida, et al.
Journal of Atherosclerosis and Thrombosis
|
April 21, 2023
Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
Shiho Masuda, Tomoyo Hara, Hiroki Yamagami, et al.
British Journal of Haematology
|
October 18, 2016
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma
Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, et al.
Oncotarget
|
October 15, 2016
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
Ariunzaya Bat-Erdene, Hirokazu Miki, Asuko Oda, et al.
Nature Communications
|
November 24, 2022
Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis
Bingzi Dong, Masahiro Hiasa, Yoshiki Higa, et al.
International Journal of Hematology
|
April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Emiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
Ejhaem
|
July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease
Hirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
BMJ Supportive & Palliative Care
|
April 3, 2024
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study
Mamiko Takahashi, Shin Kondo, Kumiko Kagawa, et al.
Journal of Diabetes Investigation
|
January 25, 2019
Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Hiroyasu Mori, Akio Kuroda, Masashi Ishizu, et al.
Diabetes Technology & Therapeutics
|
October 30, 2012
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump
Akio Kuroda, Tetsuyuki Yasuda, Mitsuyoshi Takahara, et al.
Journal of Atherosclerosis and Thrombosis
|
May 16, 2017
The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice
Kiyoe Kurahashi, Seika Inoue, Sumiko Yoshida, et al.
Journal of Atherosclerosis and Thrombosis
|
April 21, 2023
Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
Shiho Masuda, Tomoyo Hara, Hiroki Yamagami, et al.
British Journal of Haematology
|
October 18, 2016
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma
Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, et al.
Oncotarget
|
October 15, 2016
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
Ariunzaya Bat-Erdene, Hirokazu Miki, Asuko Oda, et al.
Nature Communications
|
November 24, 2022
Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis
Bingzi Dong, Masahiro Hiasa, Yoshiki Higa, et al.
International Journal of Hematology
|
April 11, 2023
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
Emiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, et al.
Page
of 12